| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Dec 31, 2008 | Dec 31, 2007 |
|---|
|
Total Revenue
|
16,230,000
|
11,168,000
|
12,509,000
|
10,123,000
| | Cost of Revenue | 4,158,000 | 2,179,000 | 1,956,000 | 2,041,000 | | |
Gross Profit
|
12,072,000
|
8,989,000
|
10,553,000
|
8,082,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 9,927,000 | 7,770,000 | 7,388,000 | 10,171,000 | | | |
Operating Income or Loss
|
6,303,000
|
3,399,000
|
5,122,000
|
(49,000)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 6,303,000 | 3,399,000 | 5,122,000 | (49,000) |
|
Interest Expense | (60,000) | (76,000) | (43,000) | (8,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | (348,000) | 1,185,000 | 1,466,000 | 1,505,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 10,511,000 | 6,870,000 | 7,848,000 | (245,000) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
10,511,000
|
6,870,000
|
7,848,000
|
(245,000)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
1.77%